Christopher Gleason is the President and Chief Executive Officer of Moximed, a role held since 2024. They previously served as Vice President of Sales at Relievant Medsystems from 2021 to 2024, a company acquired by Boston Scientific in November 2023. Their career includes leadership roles at NeoTract (Area Sales Director, 2016–2019), Teleflex (National Sales Director, 2020–2021), Intuitive Surgical (Clinical Sales Representative, 2007–2008; Clinical Sales Manager), Acclarent/Johnson & Johnson (Regional Sales Manager, 2011–2015), Xenex Disinfection Services (Director of Business Development & Sales, Western US, 2015–2016), and Johnson & Johnson (District Sales Manager, 2006–2007; Senior Sales Representative). They earned an MBA from Indiana University's Kelley School of Business (2005–2007) and served as a Captain in the United States Army from 1996 to 2000 as a Nuclear, Biological, and Chemical Warfare Officer.
This person is not in the org chart
This person is not in any teams
This person is not in any offices